Javascript must be enabled to continue!
Streamlining Grant Applications - What are the probabilities a streamlined grant is fundable and that a fundable grant is streamlined?
View through CrossRef
Background: Securing qualified peer reviewers for public granting agencies is challenging and to avoid needlessly overworking these volunteers, there is increasing reliance on triaging grants deemed unlikely to be competitive. For example, Canadian Institute for Health Research (CIHR), our largest public funder, has a stream-lining process whereby if the average of three initial reviewer scores is < 4.0, the submission is automatically triaged.Methods: Using Bayesian methods to account for the uncertainty in the re-viewers’ score, small sample sizes and vague prior beliefs, the true mean posterior(updated) distribution of a streamlined grant was calculated, including the probability it exceeds the threshold. The predictive distribution a new single reviewer, or a group of reviewers, might accord the streamlined grant while incorporating the aforementioned uncertainties was also calculated. Finally, the probability a submission with a true value > 4 could be streamlined was also calculated.Results: Simulations suggest that grants with mean scores slightly below 4 may have significant probabilities (30-50%) of being fundable, when reviewer variability is high. The mean probability that a new reviewer would rate a previously streamlined grant with a score > 4 was 48% (95% confidence interval (CI)0.13 - 0.86). The average probability that 15 new reviewers would rate the sestreamlined grants > 4 was 44% (95% CI 7 - 93). Simulations suggest that even streamlined grants with scores of 3.7 or 3.8, if associated with high reviewer variations, may have at least a 30% probability that the next reviewer score is > 4. Simulations also show that fundable grants, those with true scores in the range of 4.1 - 4.3, have a 20-40% probability of being streamlined.Conclusions: This study emphasizes the need to reevaluate streamlining mechanisms to increase the fairness and accuracy of the evaluation process. Agencies should consider adjusting thresholds or requiring additional reviews for streamlined applications with high variability to avoid excluding potentially fundable grants from full committee consideration.
Title: Streamlining Grant Applications - What are the probabilities a streamlined grant is fundable and that a fundable grant is streamlined?
Description:
Background: Securing qualified peer reviewers for public granting agencies is challenging and to avoid needlessly overworking these volunteers, there is increasing reliance on triaging grants deemed unlikely to be competitive.
For example, Canadian Institute for Health Research (CIHR), our largest public funder, has a stream-lining process whereby if the average of three initial reviewer scores is < 4.
0, the submission is automatically triaged.
Methods: Using Bayesian methods to account for the uncertainty in the re-viewers’ score, small sample sizes and vague prior beliefs, the true mean posterior(updated) distribution of a streamlined grant was calculated, including the probability it exceeds the threshold.
The predictive distribution a new single reviewer, or a group of reviewers, might accord the streamlined grant while incorporating the aforementioned uncertainties was also calculated.
Finally, the probability a submission with a true value > 4 could be streamlined was also calculated.
Results: Simulations suggest that grants with mean scores slightly below 4 may have significant probabilities (30-50%) of being fundable, when reviewer variability is high.
The mean probability that a new reviewer would rate a previously streamlined grant with a score > 4 was 48% (95% confidence interval (CI)0.
13 - 0.
86).
The average probability that 15 new reviewers would rate the sestreamlined grants > 4 was 44% (95% CI 7 - 93).
Simulations suggest that even streamlined grants with scores of 3.
7 or 3.
8, if associated with high reviewer variations, may have at least a 30% probability that the next reviewer score is > 4.
Simulations also show that fundable grants, those with true scores in the range of 4.
1 - 4.
3, have a 20-40% probability of being streamlined.
Conclusions: This study emphasizes the need to reevaluate streamlining mechanisms to increase the fairness and accuracy of the evaluation process.
Agencies should consider adjusting thresholds or requiring additional reviews for streamlined applications with high variability to avoid excluding potentially fundable grants from full committee consideration.
Related Results
619. Pharmacokinetic-Pharmacodynamic (PK-PD) Target Attainment Analyses to Support Epetraborole Dose Selection for the Treatment of Patients with Mycobacterium avium Complex (MAC) Lung Disease
619. Pharmacokinetic-Pharmacodynamic (PK-PD) Target Attainment Analyses to Support Epetraborole Dose Selection for the Treatment of Patients with Mycobacterium avium Complex (MAC) Lung Disease
Abstract
Background
Epetraborole (EBO) is an orally available, bacterial leucyl transfer RNA synthetase inhibitor that concentra...
LB2306. Population Pharmacokinetic (PPK), Pharmacokinetic/Pharmacodynamic attainment (PTA), and Clinical Pharmacokinetic/Pharmacodynamic (PK/PD) Analyses for Sulbactam-Durlobactam (SUL-DUR) to Support Dose Selection for the Treatment of Acinetobacter baum
LB2306. Population Pharmacokinetic (PPK), Pharmacokinetic/Pharmacodynamic attainment (PTA), and Clinical Pharmacokinetic/Pharmacodynamic (PK/PD) Analyses for Sulbactam-Durlobactam (SUL-DUR) to Support Dose Selection for the Treatment of Acinetobacter baum
Abstract
Background
SUL-DUR is a β-lactam/β-lactamase inhibitor combination in development for the treatment of ABC infections, ...
593. Population Pharmacokinetic Model Development for Epetraborole and Mycobacterium avium Complex (MAC) Lung Disease Patients Using Data from Phase 1 and 2 Studies
593. Population Pharmacokinetic Model Development for Epetraborole and Mycobacterium avium Complex (MAC) Lung Disease Patients Using Data from Phase 1 and 2 Studies
Abstract
Background
Epetraborole (EBO), an orally available bacterial leucyl transfer RNA synthetase inhibitor with potent activ...
592. Impact of Elevated MIC Values on Echinocandin Pharmacokinetic-Pharmacodynamic (PK-PD) Candida glabrata Target Attainment (TA)
592. Impact of Elevated MIC Values on Echinocandin Pharmacokinetic-Pharmacodynamic (PK-PD) Candida glabrata Target Attainment (TA)
Abstract
Background
Given the increasing prevalence of non-albicans Candida species, including C. glabrata and C. auris, which h...
Interrogating the lava hypothesis for the origin of Kasei Valles with analyses of streamlined island morphometry
Interrogating the lava hypothesis for the origin of Kasei Valles with analyses of streamlined island morphometry
Introduction: Outflow channels are the largest erosive structures on Mars [1,2,3,4]. Their formation postdates that of most valley networks, at the Hesperian-Amazonian transition...
P-501. Implementation of an Active Congenital Cytomegalovirus Screening Program in a Large Pediatric Hospital System. Key Findings and Lessons Learned
P-501. Implementation of an Active Congenital Cytomegalovirus Screening Program in a Large Pediatric Hospital System. Key Findings and Lessons Learned
Abstract
Background
Congenital cytomegalovirus (cCMV) infection is the most common congenital infection. Cleveland Clinic...
Figs S1-S9
Figs S1-S9
Fig. S1. Consensus phylogram (50 % majority rule) resulting from a Bayesian analysis of the ITS sequence alignment of sequences generated in this study and reference sequences from...
Credit rating change and change in firm’s probabilities of default
Credit rating change and change in firm’s probabilities of default
This thesis provides new empirical evidence on the credit risk literature. Rating agencies regularly measure the probabilities of default on current and historical data, they are n...

